⚡️We are now posting daily S-gene target failure (SGTF) data – a proxy for Omicron – from clinical testing @ynhh (Connecticut) on our website. That way I don’t need to write a thread every day 😉
The data are located on our weekly variant report (though I will *try* to update daily). If you scroll down below the summary table, you’ll see the interactive figure. There you can find the data that underline the trends. (2/5)
Again, here is a thread explaining the presented SGTF data and their limitations. I highly recommend reading this – especially if you are a journalist reporting on these data. (3/5)
I want to thank Marie Landry and David Peaper for providing their diagnostic data, Andreas Coppi, Dave Ferguson, and @wade_schulz for generating the automated daily reports, and @ChaneyKalinich for setting this up on our website. 👏(5/5)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
S-gene target failure (SGTF) data (a proxy for omicron) from yesterday took a big leap from 12% to 30%, which may end up being a bit of an outlier (noise w/ small n). Regardless, the % keeps rising fast, and we predict that Omicron will >50% in this population within days. (2/5)
The above data does not represent all of Connecticut – only parts of Fairfield and New Haven Counties. Other areas may be lagging behind, though at this rate Omicron could reach dominance (>50%) across the state by the end of the month. (3/5)
We can now track daily TaqPath tests from Yale New Haven Hospital, and of the pos tests with ORF target < 30 CT, report the fraction likely Omicron (SGTF) and Delta (non-SGTF).
From tests on Dec 13, *23/214 (9.7%)* had a SGTF
Explanation & caveats in 🧵
Our data represent a fraction of the samples tested by YNHH, and the catchment is primarily New Haven and Fairfield Counties. So they don’t represent all of Connecticut. I’ve heard from others tracking SGTFs elsewhere in the state that they are not seeing a high % yet. (2/11)
Not all non-SGTFs are Delta and not all SGTFs are Omicron (see BA.2). But of the 184 sequences on GISAID from the US collected after 11/25 with the spike 69/70 del that causes SGTF:
(2/6) The CDC N1 probe mismatch in Omicron is a C28311T mutation. Of the 91 B.1.1.529 sequences on GISAID:
- 48 have a T (mismatch)
- 19 have a C (exact match)
- 26 have no coverage (NNNs)
(3/6) All of the Omicron sequences with a C at 28,311 (exact match to N1 probe) are from the CERI-KRISP group, so maybe @Tuliodna can provide some info if these are potentially a sequencing artifact (which we've seen with Delta) or if this site is variable within the lineage
Like Alpha (B.1.1.7), B.1.1.529 has the spike 69-70 deletion that causes a S-gene target failure (SGTF) when using the ThermoFisher TaqPath COVID-19 assay. Because most other variants didn't have the deletion, this was helpful for tracking Alpha (1/8)
Likewise, reporting SGTFs will be extremely helpful again for tracking the spread & growth of B.1.1.529, like the amazing folks in South Africa are already demonstrating (2/8)
While the ThermoFisher TaqPath COVID-19 assay is very common, not everyone is using it; and while sequencing is required to confirm B.1.1.529 cases, slow turn-around times can delay its tracking. Here is where other PCR screening assays can be helpful (3/8)
The Delta sublineage leaderboard remained virtually unchanged this week (boring is good), though things could get very interesting through the holidays. (2/4)
Unfortunately, we are going into the holidays with transmission and infections estimated to be rising in Connecticut (and across the US). (3/4)